Cargando…

Downregulation of GPSM2 is associated with primary resistance to paclitaxel in breast cancer

Paclitaxel is one of the most effective chemotherapy drugs for breast cancer worldwide but 20–30% patients show primary resistance to the drug. Screening and identification of markers that facilitate effective and rapid prediction of sensitivity to paclitaxel is therefore an urgent medical requireme...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Zhe, Li, Zhi, Deng, Mingming, Liu, Bofang, Xin, Xing, Zhao, Zhenkun, Zhang, Ye, Lv, Qingjie
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2020
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7041173/ https://www.ncbi.nlm.nih.gov/pubmed/32020211 http://dx.doi.org/10.3892/or.2020.7471

Ejemplares similares

Localization of GPSM2 in the Nucleus of Invasive Breast Cancer Cells Indicates a Poor Prognosis
por: Deng, Mingming, et al.
Publicado: (2020)

Identifying GPSM Family Members as Potential Biomarkers in Breast Cancer: A Comprehensive Bioinformatics Analysis
por: Dang, Huy-Hoang, et al.
Publicado: (2021)

GPSM2 Serves as an Independent Prognostic Biomarker for Liver Cancer Survival
por: Yang, Dingquan, et al.
Publicado: (2020)

GPSM1 impairs metabolic homeostasis by controlling a pro-inflammatory pathway in macrophages
por: Yan, Jing, et al.
Publicado: (2022)

Interaction between Discs large and Pins/LGN/GPSM2: a comparison across species
por: Schiller, Emily A., et al.
Publicado: (2021)

SYTL4 downregulates microtubule stability and confers paclitaxel resistance in triple-negative breast cancer
por: Liu, Xi-Yu, et al.
Publicado: (2020)

Knockdown of G‐protein‐signaling modulator 2 promotes metastasis of non‐small‐cell lung cancer by inducing the expression of Snail
por: Deng, Mingming, et al.
Publicado: (2020)

Paclitaxel exposure downregulates miR-522 expression and its downregulation induces paclitaxel resistance in ovarian cancer cells
por: Miyamoto, Mayuko, et al.
Publicado: (2020)

Genetic variations in GPSM3 associated with protection from rheumatoid arthritis affect its transcript abundance
por: Gall, BJ, et al.
Publicado: (2016)

Molecular and Clinical Characterization of a Novel Prognostic and Immunologic Biomarker GPSM3 in Low-Grade Gliomas
por: Wang, Ming, et al.
Publicado: (2021)

RGS12 polarizes the GPSM2-GNAI complex to organize and elongate stereocilia in sensory hair cells
por: Akturk, Anil, et al.
Publicado: (2022)

LZTS1 downregulation confers paclitaxel resistance and is associated with worse prognosis in breast cancer
por: Lovat, Francesca, et al.
Publicado: (2013)

Knockdown of GPSM1 Inhibits the Proliferation and Promotes the Apoptosis of B-Cell Acute Lymphoblastic Leukemia Cells by Suppressing the ADCY6-RAPGEF3-JNK Signaling Pathway
por: Zhang, Ye, et al.
Publicado: (2021)

The Asymmetric Cell Division Regulators Par3, Scribble and Pins/Gpsm2 Are Not Essential for Erythroid Development or Enucleation
por: Wölwer, Christina B., et al.
Publicado: (2017)

Depletion of GPSM1 enhances ovarian granulosa cell apoptosis via cAMP-PKA-CREB pathway in vitro
por: Cai, Xuzi, et al.
Publicado: (2020)

Truncated isoforms of GPSM2 containing the GoLoco motif region promote CD4(+) T-cell migration in SLE
por: Esser, Ruth L, et al.
Publicado: (2022)

Role of the progesterone receptor for paclitaxel resistance in primary breast cancer
por: Schmidt, M, et al.
Publicado: (2007)

Tumour suppressor EP300, a modulator of paclitaxel resistance and stemness, is downregulated in metaplastic breast cancer
por: Asaduzzaman, Muhammad, et al.
Publicado: (2017)

Reduction of GPSM3 expression akin to the arthritis-protective SNP rs204989 differentially affects migration in a neutrophil model
por: Gall, BJ, et al.
Publicado: (2016)

Synergistic Antitumor Effects on Drug-Resistant Breast Cancer of Paclitaxel/Lapatinib Composite Nanocrystals
por: Wang, Jun, et al.
Publicado: (2020)

Downregulation of CDH11 Promotes Metastasis and Resistance to Paclitaxel in Gastric Cancer Cells
por: Yang, Zhongyin, et al.
Publicado: (2021)

EPAS1 targeting by miR-152-3p in Paclitaxel-resistant Breast Cancer
por: Song, Ying, et al.
Publicado: (2020)

Promotion of row 1–specific tip complex condensates by Gpsm2-Gαi provides insights into row identity of the tallest stereocilia
por: Shi, Yingdong, et al.
Publicado: (2022)

Paclitaxel resistance is mediated by NF-κB on mesenchymal primary breast cancer cells
por: Esparza-López, José, et al.
Publicado: (2022)

Defective Gpsm2/Gα(i3) signalling disrupts stereocilia development and growth cone actin dynamics in Chudley-McCullough syndrome
por: Mauriac, Stephanie A., et al.
Publicado: (2017)

Unveiling novel targets of paclitaxel resistance by single molecule long-read RNA sequencing in breast cancer
por: Lian, Bi, et al.
Publicado: (2019)

Long non-coding RNA ENST00000500843 is downregulated and promotes chemoresistance to paclitaxel in lung adenocarcinoma
por: Tian, Xin, et al.
Publicado: (2019)

Penfluridol overcomes paclitaxel resistance in metastatic breast cancer
por: Gupta, Nehal, et al.
Publicado: (2019)

Paclitaxel targets FOXM1 to regulate KIF20A in mitotic catastrophe and breast cancer paclitaxel resistance
por: Khongkow, P, et al.
Publicado: (2016)

GSK2801 Reverses Paclitaxel Resistance in Anaplastic Thyroid Cancer Cell Lines through MYCN Downregulation
por: Molteni, Elisabetta, et al.
Publicado: (2023)

Role of aurora kinase B in regulating resistance to paclitaxel in breast cancer cells
por: Liu, Min, et al.
Publicado: (2022)

Fabrication of paclitaxel hybrid nanomicelles to treat resistant breast cancer via oral administration
por: Dian, Ling-Hui, et al.
Publicado: (2018)

Author Correction: Defective Gpsm2/Gα(i3) signalling disrupts stereocilia development and growth cone actin dynamics in Chudley-McCullough syndrome
por: Mauriac, Stephanie A., et al.
Publicado: (2018)

Cold Atmospheric Plasma Restores Paclitaxel Sensitivity to Paclitaxel-Resistant Breast Cancer Cells by Reversing Expression of Resistance-Related Genes
por: Park, Sungbin, et al.
Publicado: (2019)

Influence of MiR-451 on Drug Resistances of Paclitaxel-Resistant Breast Cancer Cell Line
por: Gu, Xi, et al.
Publicado: (2015)

Angiogenesis and lymphangiogenesis are downregulated in primary breast cancer
por: Boneberg, E-M, et al.
Publicado: (2009)

Dual functionalized hyaluronic acid micelles loading paclitaxel for the therapy of breast cancer
por: Liu, Zhanbiao, et al.
Publicado: (2023)

Involvement of miR-451 in resistance to paclitaxel by regulating YWHAZ in breast cancer
por: Wang, Wenrui, et al.
Publicado: (2017)

Prodrug Strategies for Paclitaxel
por: Meng, Ziyuan, et al.
Publicado: (2016)

Paclitaxel Resistance Modulated by the Interaction between TRPS1 and AF178030.2 in Triple-Negative Breast Cancer
por: Zhao, Tao, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_tcic4ji0glsjufj6e310psn0p3